tiprankstipranks
IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial
PremiumPress ReleasesIO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial
5M ago
IO Biotech announces first patient dosed in Phase 2 trial of IO102-IO103
PremiumThe Fly
IO Biotech announces first patient dosed in Phase 2 trial of IO102-IO103
5M ago
IO Biotech appoints Helen Collins to board of directors
PremiumThe Fly
IO Biotech appoints Helen Collins to board of directors
6M ago
IO Biotech presents three posters at SITC meeting
PremiumThe FlyIO Biotech presents three posters at SITC meeting
6M ago
IO Biotech Presents Three Posters at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
PremiumPress Releases
IO Biotech Presents Three Posters at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
6M ago
Encouraging Preliminary Data from a Phase 2 Trial Evaluating IO102-IO103 in Combination with Pembrolizumab for First-line Treatment of Patients with Non-small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck Presented at the European Society for Medical Oncology (ESMO) Congress
PremiumPress Releases
Encouraging Preliminary Data from a Phase 2 Trial Evaluating IO102-IO103 in Combination with Pembrolizumab for First-line Treatment of Patients with Non-small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck Presented at the European Society for Medical Oncology (ESMO) Congress
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100